| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Benevich Eric is a Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $8.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,600 | $107.40 | $171,836.00 | -4.2% | +1.0% | +38.1% | |
| Feb 8, 2023 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 19,650 | $102.70 | $2,018,104.78 | -15.7% | -6.9% | +28.6% | |
| Jan 31, 2023 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,207 | $109.95 | $132,710.25 | -6.7% | -6.2% | +26.0% | |
| Jan 6, 2023 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 400 | $125.00 | $50,000.00 | -2.5% | -14.8% | +7.7% | |
| Nov 30, 2022 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 50,000 | $125.90 | $6,295,085.00 | -51.6% | -18.9% | -8.2% | |
| Nov 10, 2022 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 24,693 | $125.33 | $3,094,855.59 | -44.1% | -15.2% | -13.0% | |
| Nov 3, 2022 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 9,368 | $125.02 | $1,171,182.95 | -23.0% | -11.2% | -9.4% | |
| Oct 17, 2022 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 4,960 | $110.82 | $549,681.58 | -24.1% | -2.5% | +2.8% | |
| Feb 8, 2022 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 5,099 | $80.57 | $410,820.89 | -6.4% | -5.2% | +30.7% | |
| Aug 16, 2021 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 5,628 | $89.62 | $504,394.87 | -26.5% | -2.7% | +17.7% |